Eiger Biopharmaceuticals Inc buy Mori8
Start price
02.10.20
/
50%
€6.75
Target price
04.11.21
-
Performance (%)
0.52%
End price
05.11.21
€6.79
Summary
This prediction ended on 05.11.21 with a price of €6.79. During the runtime of the prediction for Eiger Biopharmaceuticals Inc the price only changed by 0.52%. Mori8 has a follow-up prediction for Eiger Biopharmaceuticals Inc where he still thinks Eiger Biopharmaceuticals Inc is a Buy. Mori8 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Eiger Biopharmaceuticals Inc | - | - | - | - |
| iShares Core DAX® | 2.112% | -0.367% | 13.466% | 16.854% |
| iShares Nasdaq 100 | -2.197% | -3.794% | 38.426% | 42.934% |
| iShares Nikkei 225® | -1.555% | -7.320% | 18.451% | 2.941% |
| iShares S&P 500 | -0.472% | -2.078% | 27.488% | 41.955% |
Comments by Mori8 for this prediction
In the thread Eiger Biopharmaceuticals Inc diskutieren
Buy Eiger Biopharmaceuticals Inc
SNY/TBIO Move COVID-19 Vaccine Into Clinic, AVXL's PDD Study Promising, EIGR On Watch
INDIANAPOLIS (dpa-AFX) - Today's Daily Dose brings you news about Eiger BioPharma's COVID-19 ILIAD study results, disappointing results of Servier/Galapagos' knee osteoarthritis drug trial, Anavex Life's Parkinson's disease dementia trial, the progress in Sanofi/Translate Bio's COVID-19 vaccine candidate MRT5500, and Lilly loosening its purse strings to bolster its pipeline with SARM1 programs for axonal degeneration.
In the thread Trading Eiger Biopharmaceuticals Inc
Die von Mori8 gewählte maximale Laufzeit wurde überschritten
Current prediction by Mori8 for Eiger Biopharmaceuticals Inc
Eiger Biopharmaceuticals Inc
Start price
Target price
Perf. (%)
€2.50
10.02.23
10.02.23
-
28.02.26
28.02.26
-92.00%
05.01.24
05.01.24
Stopped prediction by Mori8 for Eiger Biopharmaceuticals Inc
Eiger Biopharmaceuticals Inc
Start price
Target price
Perf. (%)
€2.10
07.02.23
07.02.23
-
07.03.23
07.03.23
18.88%
10.02.23
10.02.23
Eiger Biopharmaceuticals Inc
Start price
Target price
Perf. (%)
€1.49
30.01.23
30.01.23
-
28.02.23
28.02.23
23.56%
02.02.23
02.02.23
Eiger Biopharmaceuticals Inc
Start price
Target price
Perf. (%)
€5.16
05.12.21
05.12.21
-
05.12.22
05.12.22
-6.11%
23.12.21
23.12.21
Eiger Biopharmaceuticals Inc
Start price
Target price
Perf. (%)
€6.66
16.11.21
16.11.21
-
16.11.22
16.11.22
-22.54%
05.12.21
05.12.21
Eiger Biopharmaceuticals Inc
Start price
Target price
Perf. (%)
€9.53
09.10.18
09.10.18
€18.00
12.06.19
12.06.19
-6.82%
12.06.19
12.06.19